User profiles for "author:P O’Connor"
Patrick J. O'ConnorSenior Clinical Investigator, HealthPartners Institute Verified email at healthpartners.com Cited by 26346 |
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
…, LM Metz, HF McFarland, PW O'Connor… - Annals of Neurology …, 2005 - Wiley Online Library
New diagnostic criteria for multiple sclerosis integrating magnetic resonance image
assessment with clinical and other paraclinical methods were introduced in 2001. The “McDonald …
assessment with clinical and other paraclinical methods were introduced in 2001. The “McDonald …
Defining the clinical course of multiple sclerosis: the 2013 revisions
…, C Lubetzki, AE Miller, X Montalban, PW O'Connor… - Neurology, 2014 - AAN Enterprises
Accurate clinical course descriptions (phenotypes) of multiple sclerosis (MS) are important
for communication, prognostication, design and recruitment of clinical trials, and treatment …
for communication, prognostication, design and recruitment of clinical trials, and treatment …
OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring …
…, P Bird, B Ejbjerg, R Shnier, P O'Connor… - The Journal of …, 2003 - jrheum.org
This article describes the 2002 OMERACT rheumatoid arthritis magnetic resonance image
scoring system (RAMRIS) for evaluation of inflammatory and destructive changes in RA …
scoring system (RAMRIS) for evaluation of inflammatory and destructive changes in RA …
[HTML][HTML] A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis
L Kappos, EW Radue, P O'Connor… - … England Journal of …, 2010 - Mass Medical Soc
Background Oral fingolimod, a sphingosine-1-phosphate–receptor modulator that prevents
the egress of lymphocytes from lymph nodes, significantly improved relapse rates and end …
the egress of lymphocytes from lymph nodes, significantly improved relapse rates and end …
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
…, FD Lublin, X Montalban, P O'Connor… - Annals of …, 2011 - Wiley Online Library
New evidence and consensus has led to further revision of the McDonald Criteria for diagnosis
of multiple sclerosis. The use of imaging for demonstration of dissemination of central …
of multiple sclerosis. The use of imaging for demonstration of dissemination of central …
[HTML][HTML] Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain
…, AM Gilson, A Kelter, A Mauskop, PG O'Connor… - The journal of pain, 2009 - Elsevier
Use of chronic opioid therapy for chronic noncancer pain has increased substantially. The
American Pain Society and the American Academy of Pain Medicine commissioned a …
American Pain Society and the American Academy of Pain Medicine commissioned a …
Musculoskeletal ultrasound including definitions for ultrasonographic pathology.
…, GAW Bruyn, G Bruyn, D Kane, PJ O'Connor… - The Journal of …, 2005 - jrheum.org
Ultrasound (US) has great potential as an outcome in rheumatoid arthritis trials for detecting
bone erosions, synovitis, tendon disease, and enthesopathy. It has a number of distinct …
bone erosions, synovitis, tendon disease, and enthesopathy. It has a number of distinct …
[HTML][HTML] A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman, PW O'Connor, E Havrdova… - … England Journal of …, 2006 - Mass Medical Soc
Background Natalizumab is the first α 4 integrin antagonist in a new class of selective
adhesion-molecule inhibitors. We report the results of a two-year phase 3 trial of natalizumab in …
adhesion-molecule inhibitors. We report the results of a two-year phase 3 trial of natalizumab in …
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
…, B Hoogwerf, D Karl, L Katz, A Krikorian, P O'Connor… - The Lancet, 2010 - thelancet.com
Background Hyperglycaemia is associated with increased risk of cardiovascular complications
in people with type 2 diabetes. We investigated whether reduction of blood glucose …
in people with type 2 diabetes. We investigated whether reduction of blood glucose …
WAF1/CIP1 Is Induced in p53-mediated G1 Arrest and Apoptosis
The tumor growth suppressor WAF1/CIP1 was recently shown to be induced by p53 and to
be a potent inhibitor of cyclin-dependent kinases. In the present studies, we sought to …
be a potent inhibitor of cyclin-dependent kinases. In the present studies, we sought to …